Key Drivers
- Profitability rebound
- Strong cash flow
- Balance-sheet risk
AIAI Summary
OSCR has shifted from a speculative ACA growth story to a cash-generative insurer with improving margins and balance-sheet flexibility, but after the sharp rerating investors should treat it as a “prove sustainability” trade where the real risk is ACA subsidy changes and medical-cost inflation undermining the new earnings base.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profitability rebound
- •Strong cash flow
- •Balance-sheet risk
OSCR delivered a meaningful turnaround in profitability and cash flow, but high leverage and only modest liquidity keep the recovery from being fully de-risked.
Price Behavior
Key Price Behavior Insights:
- •Breakout Hold
- •Strong Momentum
- •Pullback Risk
OSCR has shown a bullish breakout over the last month, and while momentum remains strong, it now needs to hold the $29.5–$28.5 support zone and clear $32.2 to avoid a short-term pullback.
Sharp late-June breakout signals fast upside momentum and near-term consolidation risk
Sentiment & News
Key News Insights:
- •Guidance reaffirmed
- •Share gains
- •Valuation caution
Oscar Health surged on strong 2026 momentum and reaffirmed guidance, but recent pullbacks and valuation concerns suggest investors should watch for volatility.
The news supports a bullish growth narrative, but near-term upside may be capped by volatility and stretched valuation
Similar Companies in Healthcare
Other companies in the same sector with AI ratings